|
Variables
|
Number of visits with a high TyG index*
|
|---|
|
0
|
1
|
2
|
3
|
P for trend
|
|---|
|
Case, n (%)
|
173 (0.70)
|
139 (1.40)
|
126 (1.40)
|
164 (1.68)
| |
|
Incidence rate, per 1000 person-y
|
0.65 (0.56–0.75)
|
1.07 (0.91–1.27)
|
1.29 (1.09–1.54)
|
1.55 (1.33–1.81)
| |
|
Model 1
|
Reference
|
1.69 (1.36–2.12)
|
2.10 (1.67–2.64)
|
2.52 (2.03–3.12)
|
< 0.0001
|
|
Model 2
|
Reference
|
1.61 (1.28–2.01)
|
1.90 (1.50–2.40)
|
2.21 (1.77–2.76)
|
< 0.0001
|
|
Model 3
|
Reference
|
1.54 (1.23–1.93)
|
1.78 (1.41–2.26)
|
2.04 (1.63–2.56)
|
< 0.0001
|
|
Sensitivity analysis
|
Reference
|
1.48 (1.16–1.91)
|
1.78 (1.37–2.31)
|
2.16 (1.69–2.78)
|
< 0.0001
|
- CI confidence interval, HR hazard ratio, TyG triglyceride glucose
- *High TyG index was defined as TyG index ≥ 8.83
- Model 1, adjusted for age and sex at baseline
- Model 2, adjusted for variables in model 1 plus level of education, income, smoking, alcohol abuse, physical activity, and BMI at baseline
- Model 3, adjusted for variables in model 2 plus SBP, DBP, a history of hypertension, diabetes mellitus, and dyslipidemia, antidiabetic drugs, lipid-lowering drugs, antihypertensive drugs, HDL-C, LDL-C, and hs-CRP at baseline
- Sensitivity analysis was adjusted for variables in model 3 and further excluded all deaths during the follow-up visits
